Skip to main content
. 2015 Aug 17;2015:249125. doi: 10.1155/2015/249125

Table 6.

Orientative therapeutic protocol for Graves' ophthalmopathy (see text for bibliographic references).

All patients Restore euthyroidism
Avoid smoking
Conservative local measures
Severity Activity
Active Nonactive
Mild (i) Artificial tears
(ii) Sunglasses
(iii) Head of the bed slightly elevated
(iv) Selenium (200 μ/g daily × 6 months)
(v) Fresnel-type prisms
(vi) Botulinum toxin in Müller muscle
(i) Artificial tears
(ii) Prisms
(iii) Botulinum toxin in Müller muscle
(iv) Surgical Müllerectomy
(v) Blepharoplasty

Moderate-severe (i) Intravenous methylprednisolone:
1st, 500 mg/week × 6 weeks
2nd, 250 mg/week × 6 weeks
3rd, if activity persists: consider prolongation of treatment up to 8 g of maximum cumulative dosage
4th If non responsive after 6 weeks, change the treatment
(ii) Patients resistant to glucocorticoids:
(a) Association of cyclosporin A (5 mg/kg/day in 2 doses) plus oral glucocorticoids, methotrexate (7,5–10 mg/week), tocilizumab (8 mg/kg/every 4 weeks), and Rituximab (500 mg–1000 mg),
(b) If muscular involvement predominates: orbital radiotherapy (20 Gy) (not in <35 years or diabetic patients)
(iii) Consider botulinum toxin in extraocular muscles if with diplopia (medial rectus or inferior rectus)
1st, orbital decompression (2 or 3 walls depending on the degree of exophthalmos)
2nd, surgery for strabismus (stability of 6-month deviation angle. Muscular recessions)
3rd, palpebral surgery
(i) Palpebral retraction: levator recession surgery, retractors for the lower eyelid.
(ii) Blepharoplasty of upper eyelids, lower eyelids, or both.

Threat to vision
 Dysthyroid optic neuropathy Methylprednisolone 1 g intravenously × 3 days, repeat after a week
If nonresponsive: urgent orbital decompression. (+/− glucocorticoids intravenously if still active +/− radiotherapy)
Urgent deep orbital medial wall decompression
 Severe exposure keratopathy Intravenous methylprednisolone when relevant orbital inflammation; palpebral closure, lubrication, tarsorrhaphy, botulinum toxin in Müller muscle, and orbital decompression if other measures are inefficient Lateral tarsorrhaphy, orbital decompression, amniotic membrane transplant, and corneal transplant